Clove Health Effects Eugenol PubMed Findings Surprise Experts
- 01. Immediate answer: what PubMed shows
- 02. Key PubMed findings at a glance
- 03. Representative PubMed studies and dates
- 04. Mechanisms researchers report
- 05. Safety, dosing, and documented harms
- 06. Representative quotes from the literature
- 07. Evidence strength and research gaps
- 08. Quick data snapshot (illustrative statistics)
- 09. Practical takeaways for readers
- 10. FAQ
Immediate answer: what PubMed shows
PubMed-indexed research collectively shows that clove (Syzygium aromaticum) and its main active compound eugenol have consistent in vitro and animal evidence for antimicrobial, anti-inflammatory, antioxidant, analgesic, and anticancer effects, while human clinical evidence is limited and high doses carry documented toxicity risks, especially to the liver and platelets.
Key PubMed findings at a glance
Major study themes on PubMed include antimicrobial activity against bacteria and fungi, anti-inflammatory mechanisms (COX/LOX modulation), antioxidant scavenging, metabolic effects (glucose/lipid modulation), and cytotoxicity against cancer cell lines; many of these are preclinical (in vitro/animal) rather than large human trials.
- Antimicrobial activity - clove oil and eugenol inhibit Staphylococcus, Pseudomonas and Candida in lab studies.
- Anti-inflammatory action - eugenol reduces markers such as COX-2 and inflammatory cytokines in animal and cell models.
- Metabolic effects - some extracts altered blood glucose and lipids in diabetic mouse models; isolated eugenol effects vary by preparation.
- Toxicity signals - high-dose exposures or concentrated clove oil can cause hepatotoxicity and inhibit platelet aggregation, posing bleeding risk.
Representative PubMed studies and dates
Publication examples from the PubMed record illustrate the distribution of evidence: a 2014 mouse/biochemistry study reported glucose and lipid improvements with an eugenol-reduced clove extract in db/db mice (Feb 22, 2014); multiple reviews and experimental articles through 2017-2022 summarized antimicrobial and anti-inflammatory mechanisms; a LiverTox monograph (2019) documented clinical hepatotoxicity after high-dose exposures.
| Year | Study type | Finding | Clinical relevance |
|---|---|---|---|
| 2014 | Animal / biochemical | erCE lowered blood glucose & triglycerides in db/db mice | Preclinical, suggests metabolic potential |
| 2017 | In vitro / topical models | CEO reduced inflammatory markers, improved wound inflammation | Supports topical anti-inflammatory use |
| 2019 | Clinical-safety monograph | High-dose eugenol linked to liver injury in overdoses | Documented toxicity risk at concentrated doses |
| 2022 | Review | Comprehensive antimicrobial, antioxidant evidence; calls for trials | Good preclinical evidence; human RCTs scarce |
Mechanisms researchers report
Biological actions proposed in PubMed articles include membrane disruption of microbes, free radical scavenging (antioxidant), inhibition of inflammatory enzymes (COX-2, 5-LOX), modulation of signaling pathways that lead to apoptosis in cancer cells (caspases, mitochondrial pathway), and interactions with glycogen phosphorylase/gluconeogenesis in metabolic studies.
- Antimicrobial: eugenol intercalates membranes and destabilizes microbial cells in vitro.
- Anti-inflammatory: eugenol downregulates COX-2 and certain cytokines in preclinical models.
- Antioxidant: eugenol donates phenolic hydrogen, showing radical-scavenging in biochemical assays.
Safety, dosing, and documented harms
Safety profile from PubMed and NCBI sources indicates that culinary amounts of cloves and typical dietary use are generally safe for most adults, while concentrated clove oil or high-dose supplements have recorded adverse events including hepatic injury and anticoagulant interactions; regulatory case reports and the LiverTox review alert clinicians to overdose risks.
Practical caution - eugenol and clove oil inhibit platelet aggregation and may increase bleeding risk when combined with warfarin, aspirin, or other antiplatelet agents; clinicians advise avoiding high oral doses and using topical eugenol cautiously in children and pregnant people.
Representative quotes from the literature
"Clove essential oil has been shown to possess antimicrobial, antifungal, antiviral, antioxidant, anti-inflammatory and anticancer properties" - review summarizing experimental literature (2017).
"Eugenol in therapeutic doses has not been implicated in causing serum enzyme elevations, but ingestions of high doses can cause severe liver injury" - LiverTox monograph (2019).
Evidence strength and research gaps
Evidence level across PubMed records is predominantly in vitro and animal (Level 3-4 evidence); systematic human randomized controlled trials (Level 1 evidence) are rare or small, creating a gap between promising preclinical signals and clinically actionable recommendations.
Research needs include standardized extract formulations, dose-ranging human safety trials, and randomized trials for specific indications such as topical analgesia, oral antimicrobial use in dentistry, and metabolic endpoints in people with diabetes.
Quick data snapshot (illustrative statistics)
Selected metrics summarized from the PubMed corpus and review papers give a snapshot of research activity and risk signals in the literature.
| Metric | Value | Source note |
|---|---|---|
| PubMed articles (approx.) | ~200-350 articles to 2024 | Includes reviews, in vitro, animal, limited clinical reports |
| Human RCTs | <10 small trials | Most clinical data are small, heterogeneous, or topical |
| Documented hepatotoxicity cases | Several case reports (since 2000s) | Monograph summary includes overdose events |
| Eugenol % in oil | 59-88% | Typical compositional range reported in reviews |
Practical takeaways for readers
Everyday use of ground cloves as a spice or in recipes poses negligible risk for most people and may contribute minor antioxidant intake, but this is not a substitute for medical treatment of disease.
- Topical dental use (low-concentration eugenol) is historically established for temporary analgesia in dentistry but should be applied by professionals.
- Supplement caution - avoid concentrated clove oil ingestion and check with a clinician before combining with anticoagulant medications.
- Research interest - monitor new human trials, especially for metabolic and antimicrobial indications; current evidence is promising but preliminary.
FAQ
Everything you need to know about Clove Health Effects Eugenol Pubmed Findings Surprise Experts
Is eugenol hepatotoxic?
Yes, concentrated eugenol has documented hepatotoxicity in overdose cases; therapeutic use in controlled low doses has not been broadly linked to clinically apparent liver injury, but published monographs recommend caution and monitoring when high doses are used.
Does clove/eugenol treat diabetes?
Preclinical animal studies show promising glucose- and lipid-lowering effects for some clove extracts, but human randomized controlled trials are insufficient to recommend clove or eugenol as an antidiabetic therapy at this time.
Can clove fight infections?
In vitro studies and systematic reviews show clove oil and eugenol inhibit many bacterial and fungal species and may act synergistically with antibiotics, but clinical evidence (human infection trials) is limited and often absent.
How should clinicians advise patients?
Advise patients that culinary clove use is generally safe, but concentrated clove oil or eugenol-containing supplements can cause liver injury and bleeding interactions; recommend avoiding high-dose self-treatment and consulting a clinician before combining with anticoagulants or other hepatically metabolized drugs.
Are cloves and eugenol safe to eat?
Culinary amounts of cloves are generally safe for most adults, but concentrated eugenol or clove oil taken orally in large amounts has been associated with liver injury and should be avoided unless supervised by a clinician.
Do PubMed studies prove clove cures disease?
No; PubMed studies provide strong preclinical evidence for multiple beneficial mechanisms, but human randomized controlled trials proving clinical efficacy for most diseases are lacking or limited.
Can eugenol interact with medications?
Yes, eugenol can inhibit platelet aggregation and potentially interact with anticoagulants or antiplatelet drugs, increasing bleeding risk; clinicians should screen for this interaction.
Should I take clove supplements for diabetes?
Not yet-animal and extract studies show glucose-lowering effects, but there is insufficient high-quality human trial evidence to recommend clove supplements for diabetes management at this time.
Where can I read the primary PubMed studies?
Search PubMed for Syzygium aromaticum, eugenol, and related review titles; key starting records include the 2014 metabolic study and the 2017 anti-inflammatory review, plus the LiverTox eugenol monograph for safety details.